231 related articles for article (PubMed ID: 34292224)
21. Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports.
Iesato Y; Tanaka M; Murata M; Kitahara J; Hirano T; Kurenuma T; Yoshida N; Murata T
BMC Ophthalmol; 2018 Nov; 18(1):284. PubMed ID: 30390650
[TBL] [Abstract][Full Text] [Related]
22. DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Chang YC; Cheng CK
Retina; 2020 Jul; 40(7):1403-1411. PubMed ID: 31181038
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Automated versus Manually Modified OCT Angiography En Face Slabs for Detection of Choroidal Neovascularization.
Siggel R; Spital C; Lentzsch A; Liakopoulos S
Ophthalmol Retina; 2020 May; 4(5):471-480. PubMed ID: 32245653
[TBL] [Abstract][Full Text] [Related]
24. POLYPOIDAL CHOROIDAL VASCULOPATHY UPON OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY.
Chan SY; Wang Q; Wang YX; Shi XH; Jonas JB; Wei WB
Retina; 2018 Jun; 38(6):1187-1194. PubMed ID: 28613216
[TBL] [Abstract][Full Text] [Related]
25. Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: A comparative study.
Singh SR; Goyal P; Parameswarappa DC; Goud A; Chhablani J
Eur J Ophthalmol; 2020 Sep; 30(5):1076-1081. PubMed ID: 31113262
[TBL] [Abstract][Full Text] [Related]
26. Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
Kim H; Lee SC; Kwon KY; Lee JH; Koh HJ; Byeon SH; Kim SS; Kim M; Lee CS
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1497-1503. PubMed ID: 26626772
[TBL] [Abstract][Full Text] [Related]
27. Novel Findings of Polypoidal Choroidal Vasculopathy via Optical Coherence Tomography Angiography.
Seong S; Choo HG; Kim YJ; Kim JY; Lee JH; Oh HS; You YS; Kim SH; Kwon OW
Korean J Ophthalmol; 2019 Feb; 33(1):54-62. PubMed ID: 30746912
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters.
Chang YS; Kim JH; Kim JW; Lee TG; Kim CG
Korean J Ophthalmol; 2016 Aug; 30(4):272-9. PubMed ID: 27478354
[TBL] [Abstract][Full Text] [Related]
29. IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Cheung CMG; Yanagi Y; Akiba M; Tan A; Mathur R; Chan CM; Yeo I; Wong TY
Retina; 2019 Sep; 39(9):1655-1663. PubMed ID: 29927796
[TBL] [Abstract][Full Text] [Related]
30. Diagnosing Polypoidal Choroidal Vasculopathy Using Color Fundus Photography, Optical Coherence Tomography, and Optical Coherence Tomography Angiography.
Park S; Lee J; Park JB; Kim ES; Yu SY; Kang MS; Kim K
Korean J Ophthalmol; 2023 Dec; 37(6):468-476. PubMed ID: 37899281
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
[TBL] [Abstract][Full Text] [Related]
32. Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.
Morimoto M; Matsumoto H; Mimura K; Akiyama H
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1891-1897. PubMed ID: 28669041
[TBL] [Abstract][Full Text] [Related]
33. BULBOSITIES AND INTERVORTEX VENOUS ANASTOMOSIS IN VENOUS OVERLOAD CHOROIDOPATHY MASQUERADING AS POLYPOIDAL CHOROIDAL VASCULOPATHY.
Ngo WK; Keshet Y; Spaide RF
Retin Cases Brief Rep; 2024 Jul; 18(4):436-441. PubMed ID: 36913669
[TBL] [Abstract][Full Text] [Related]
34. Association of Vascular Versus Avascular Subretinal Hyperreflective Material With Aflibercept Response in Age-related Macular Degeneration.
Kawashima Y; Hata M; Oishi A; Ooto S; Yamashiro K; Tamura H; Miyata M; Uji A; Ueda-Arakawa N; Tsujikawa A
Am J Ophthalmol; 2017 Sep; 181():61-70. PubMed ID: 28669776
[TBL] [Abstract][Full Text] [Related]
35. REDUCED VASCULAR DENSITY IN THE CHOROID AFTER TREATMENT WITH PHOTODYNAMIC THERAPY COMBINED WITH AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.
Mukai R; Matsumoto H; Miyakubo T; Akiyama H
Retina; 2021 Jan; 41(1):156-161. PubMed ID: 32251239
[TBL] [Abstract][Full Text] [Related]
36. Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography.
Tamura H; Tsujikawa A; Otani A; Gotoh N; Sasahara M; Kameda T; Iwama D; Yodoi Y; Mandai M; Yoshimura N
Br J Ophthalmol; 2007 Sep; 91(9):1152-9. PubMed ID: 17314148
[TBL] [Abstract][Full Text] [Related]
37. A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept-Source Optical Coherence Tomography Angiography.
Kim K; Yang J; Feuer W; Gregori G; Kim ES; Rosenfeld PJ; Yu SY
Am J Ophthalmol; 2020 Sep; 217():240-251. PubMed ID: 32445699
[TBL] [Abstract][Full Text] [Related]
38. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
Sakurada Y; Sugiyama A; Tanabe N; Kikushima W; Kume A; Iijima H
Retina; 2017 Oct; 37(10):1866-1872. PubMed ID: 28002268
[TBL] [Abstract][Full Text] [Related]
39. Differences between young and elderly polypoidal choroidal vasculopathy patients with and without pachychoroid phenotypes.
Wang Y; Zhang W; Yang J; Zhao X; Meng L; Chen Y; Zhang X;
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1765-1776. PubMed ID: 38231247
[TBL] [Abstract][Full Text] [Related]
40. SENSITIVITY AND SPECIFICITY OF DETECTING POLYPOIDAL CHOROIDAL VASCULOPATHY WITH EN FACE OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
de Carlo TE; Kokame GT; Kaneko KN; Lian R; Lai JC; Wee R
Retina; 2019 Jul; 39(7):1343-1352. PubMed ID: 29561386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
